Cross-departmental discussions on cooperation and cohesion, strict management of the whole chain and innovative development of the pharmaceutical industry

Recently, the Second Branch of the Provincial Food and Drug Administration has joined hands with departments of science and technology, industry and information technology, market supervision and other departments to carry out cross-departmental discussions in good faith, build an exchange platform and collaboration mechanism, promote information sharing and reference and promotion, and promote the strict management of the whole chain of drug safety and the high-quality development of the industry.

The first is to build a joint supervision mechanism. Give full play to the advantages of stationing, strictly implement the "four strictest" requirements, conscientiously perform daily inspection, rectification and review, illegal investigation and other duties and tasks, urge enterprises to implement the main responsibility, strengthen quality and safety control, and strictly abide by the bottom line of drug safety. Communicate regularly and closely cooperate with functional departments such as science and technology, industry and information technology, and market supervision, fully listen to the opinions and suggestions of drug regulatory authorities, help improve regulatory measures, innovate and improve regulatory mechanisms, and maximize the cohesion of drug regulatory synergy.

The second is to establish an information sharing mechanism. Focus on the high-quality development of the industry, and regularly invite functional departments to interpret policies. Interpret and publicize with the industry and information technology department on the consistency evaluation of generic drugs, the blue drug library development plan, and the high-quality development of the biomedical and medical device industry chain, so that the majority of enterprises can understand and familiarize themselves with the policy and make good use of it. Intervene and communicate with science and technology departments in advance on first-class innovative drugs, third-class medical devices, drug clinical trials, etc., encourage and guide enterprises to rationally innovate layout, clarify the direction of research and development, and help enterprises accelerate the pace of innovation and product launch. At the same time, the sub-bureau actively publicized and interpreted a series of policies and measures such as 23 articles of the provincial bureau to promote the high-quality development of the pharmaceutical industry, 30 articles of traditional Chinese medicine, and 16 articles of medical devices, so as to release policy dividends and stimulate the vitality of industrial innovation.

The third is to build a mechanism for innovation and joint promotion. Carry out solid thematic education research, promote the formation of research results as soon as possible, and discuss and exchange research results with relevant functional departments. Focusing on building a "Ocean Beauty Valley" to promote the high-quality development of the cosmetics industry, we will fully learn from the experience of other provinces, discuss issues such as plant layout, development and utilization of new cosmetic raw materials, supply of raw and auxiliary materials and packaging materials, design and research and development, and regularly jointly organize symposiums and salons on the high-quality development of the industry, and make efforts to help enterprises give full play to the advantages of marine resource raw materials such as sodium alginate, trehalose, chitosaccharides, and sea cucumbers, and cultivate large-scale enterprises and advantageous products. At the same time, we will strengthen communication and exchanges on issues such as first-class innovative drugs, third-class medical devices, the transformation of classic prescriptions, and the establishment of new modern logistics enterprises, in policy formulation, publicity and implementation.

The fourth is to build a normal long-term mechanism. Through regular sincere discussion activities, establish an industrial development exchange group, and implement quarterly information notification, exchange and cooperation mechanism. On the basis of strict supervision and keeping the bottom line, the second sub-bureau actively publicizes the industrial development policies of the provincial bureau and the resident government, timely grasps the needs of enterprise achievement transformation, innovation project declaration, etc., and timely notifies relevant departments. At the same time, give full play to the functional advantages of the science and technology department in the transformation of innovation achievements, technical research and the industry and information technology department in policy formulation and project review, etc., implement normalized assistance and long-term support for enterprises, and promote the innovation and development of the pharmaceutical industry.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW